PrEPared to choose: the protocol for an implementation study of the delivery of cabotegravir long-acting injectable pre-exposure prophylaxis (PrEP) as an HIV prevention product option within a real world PrEP choice context in cape town

Sprute R, Singh S, Conti HR, Cornely OA, van de Veerdonk FL, Carvalho A, Ibrahim AS. Immunotherapy for invasive Candida infections: Translating host-directed strategies into[...]

Hoffman R, Watanabe M, Martínez E, Zanni MV, Pozniak A, Shakil SS, McCallum S, Chu SM, Srinivasa S, Malvestutto CD, Fichtenbaum CJ, Bloomfield GS, Lu[...]

Duarte MJ, Tien PC, Kuniholm MH, Ma Y, Thio CL, Hanna DB, Witt MD, Skvarca C, Brock J, French AL, Alcaide M, Floris-Moore M, Seaberg[...]